<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04967001</url>
  </required_header>
  <id_info>
    <org_study_id>KY20212032-F-1</org_study_id>
    <nct_id>NCT04967001</nct_id>
  </id_info>
  <brief_title>68Ga-PSMA PET in the Prostate Cancer</brief_title>
  <official_title>Efficacy of 68Ga PSMA PET in the Diagnosis of Lymph Node Metastasis in Patients With Prostate Cancer: a Single Center Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy of 68Ga PSMA PET / CT in the diagnosis of lymph node metastasis in patients with&#xD;
      prostate cancer: a single center prospective randomized controlled trial.&#xD;
&#xD;
      To identify and compare the diagnostic efficacy of 68Ga-PSMA PET/CT and mpMRI for lymph nodes&#xD;
      in patients with newly diagnosed prostate cancer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of PSMA PET and combined PSMA PET/MRI or PSMA PET/CT</measure>
    <time_frame>2 years</time_frame>
    <description>To compare the diagnostic accuracy of PSMA PET and combined PSMA PET/MRI or PET/CT to that of the current standard multiparametric MRI, using histopathology as the gold standard.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Prostatic Neoplasms</condition>
  <condition>Metastases</condition>
  <condition>PSMA-PET</condition>
  <arm_group>
    <arm_group_label>PSMAPET-MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>MRI-PSMAPET</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PSMA PET</intervention_name>
    <description>68Ga-PSMA PET</description>
    <arm_group_label>MRI-PSMAPET</arm_group_label>
    <arm_group_label>PSMAPET-MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - High risk localized/locally advanced prostate cancer patients who are candidates for&#xD;
        radical prostatectomy plus bilateral extended PLND; ISUP Gleason grade group â‰¥ 4&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Prior history of any other cancer the last 5 years excluding basal cell carcinoma Proven&#xD;
        metastases in bones or other distant metastases General contra-indications for MRI&#xD;
        (pacemaker, aneurysm clips, any form of metal in the body, severe claustrophobia) Serious&#xD;
        concomitant systemic disorders that in the opinion of the investigator would compromise the&#xD;
        patient's ability to complete the study or interfere with the evaluation of the efficacy&#xD;
        and safety of the study objectives Metal implants in the pelvic region which will&#xD;
        deteriorate PET/MR/CT image quality.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shannxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanyan Jia</last_name>
      <phone>+86 029 8477 1794</phone>
      <email>jiayanyan-2004@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 11, 2021</study_first_submitted>
  <study_first_submitted_qc>July 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2021</study_first_posted>
  <last_update_submitted>July 11, 2021</last_update_submitted>
  <last_update_submitted_qc>July 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xijing Hospital</investigator_affiliation>
    <investigator_full_name>Qin Weijun</investigator_full_name>
    <investigator_title>Professor and Director, Department of Urology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

